{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:45:31Z","timestamp":1794663931541,"version":"4.9.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T00:00:00Z","timestamp":1292544000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>Morikawa T, Maeda D, Kume H, Homma Y &amp; Fukayama M\u2028(2010) <jats:italic>Histopathology<\/jats:italic><jats:bold>57,<\/jats:bold> 885\u2013892<\/jats:p><jats:p> <jats:bold>Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer<\/jats:bold> <\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> To examine the immunohistochemical expression and function of ribonucleotide reductase M2 subunit (RRM2), a gemcitabine\u2010related molecule, in bladder cancer.<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> One hundred and seventeen bladder specimens on a tissue microarray were immunostained for RRM2. Positive RRM2 staining was observed in none of 14 examples of non\u2010neoplastic urothelium, none of four low\u2010grade urothelial carcinoma (UC), 69 of 83 (83%) high\u2010grade UC, three of three (100%) squamous cell carcinoma and 12 of 13 (92%) lymph node metastasis of UC. RRM2 overexpression was associated significantly with muscularis propria invasion in UC patients who had undergone radical cystectomy (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.005). Immunohistochemistry for RRM2 was then applied to small biopsy specimens of 15 cystitis with reactive atypia cases and 25 urothelial carcinoma <jats:italic>in\u2010situ<\/jats:italic> (CIS) cases. Positive RRM2 staining was found in one of 15 (6.7%) cystitis with reactive atypia cases and in 24 of 25 (96%) CIS cases. Finally, UM\u2010UC\u20103 bladder cancer cells were transfected with <jats:italic>RRM2<\/jats:italic> siRNAs and cell growth was evaluated. Knockdown of RRM2 protein markedly inhibited cell growth.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> We have shown frequent overexpression of RRM2 protein and its possible role in bladder cancer. Our results suggest that RRM2 is a novel diagnostic marker and a potential therapeutic target in bladder cancer.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2010.03725.x","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T10:04:04Z","timestamp":1292580244000},"page":"885-892","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer"],"prefix":"10.1111","volume":"57","author":[{"given":"Teppei","family":"Morikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fukayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,17]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/03008880802285032"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42387-1"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8199"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.17.3068"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/S0021-9258(18)89423-6","article-title":"Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2\u2010overproducing mouse cells","volume":"260","author":"Thelander M","year":"1985","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/03602530902741828"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1016\/S0021-9258(19)68780-6","article-title":"Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle\u2010dependent variation in the activity of subunit protein M2","volume":"256","author":"Eriksson S","year":"1981","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207272"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-007-2017-0"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.12.177"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-11"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2007.n.007"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604344"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-002-0633-x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4_38"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2787"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200108000-00013"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/01913120490275213"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0603"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000056628.38714.5D"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0845-0"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2008.40.3.345"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867054020981"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0977-x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23043"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2010.03725.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2010.03725.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:20:30Z","timestamp":1697354430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2010.03725.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1365-2559.2010.03725.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03725.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"2010-12-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}